Large Molecule Drug Development for the Treatment of Myasthenia Gravis
Time: 9:30 am
day: Day Two
Details:
- Showcasing disease-specific proteins as a technology for antigen delivery
- Discussing applications in two different indications
- Sharing thoughts on translation to the clinic
